Association of ACE Gene I/D Polymorphisms with Metabolic Syndrome and Type 2 Diabetes in a Jordanian Cohort
Metabolic syndrome (MetS) is consisted of central obesity, raised blood pressure, insulin resistance, and dyslipidemia, it significantly increases the risk of cardiovascular disease and Type 2 diabetes mellitus (T2DM). MetS prevalence globally is estimated to be between 14% to 32% making MetS a significant a critical p...